• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病和非酒精性脂肪性肝炎在美国和世界其他地区的流行病学。

Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in the United States and the Rest of the World.

机构信息

Betty and Guy Beatty Center for Integrated Research, Inova Fairfax Hospital, Claude Moore Health Education and Research Building, 3300 Gallows Road, Falls Church, VA 22042, USA.

Betty and Guy Beatty Center for Integrated Research, Inova Fairfax Hospital, Claude Moore Health Education and Research Building, 3300 Gallows Road, Falls Church, VA 22042, USA; Department of Medicine, Center for Liver Diseases, Inova Fairfax Hospital, 300 Gallows Road, Falls Church, VA 22042, USA.

出版信息

Clin Liver Dis. 2016 May;20(2):205-14. doi: 10.1016/j.cld.2015.10.001. Epub 2015 Dec 14.

DOI:10.1016/j.cld.2015.10.001
PMID:27063264
Abstract

Nonalcoholic fatty liver disease (NAFLD) is a common cause of chronic liver disease with increasing prevalence, which can progress to cirrhosis and liver failure. Because of the obesity epidemic and increasing prevalence of metabolic syndrome, NAFLD and its progressive form, nonalcoholic steatohepatitis, are seen more commonly in different parts of the world. This article reviews the worldwide epidemiology of NAFLD and nonalcoholic steatohepatitis. The PubMed database was used to identify studies related to epidemiology of NAFLD in the adult population. It is estimated that the epidemic of obesity will continue to fuel the burden of NAFLD and its long-term complications.

摘要

非酒精性脂肪性肝病(NAFLD)是一种常见的慢性肝病,其发病率不断增加,可进展为肝硬化和肝衰竭。由于肥胖症的流行和代谢综合征的发病率不断上升,NAFLD 及其进展形式——非酒精性脂肪性肝炎,在世界不同地区更为常见。本文综述了 NAFLD 和非酒精性脂肪性肝炎的全球流行病学。利用 PubMed 数据库,检索与成人 NAFLD 流行病学相关的研究。据估计,肥胖症的流行将继续加剧 NAFLD 及其长期并发症的负担。

相似文献

1
Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in the United States and the Rest of the World.非酒精性脂肪性肝病和非酒精性脂肪性肝炎在美国和世界其他地区的流行病学。
Clin Liver Dis. 2016 May;20(2):205-14. doi: 10.1016/j.cld.2015.10.001. Epub 2015 Dec 14.
2
Clinical epidemiology and disease burden of nonalcoholic fatty liver disease.非酒精性脂肪性肝病的临床流行病学和疾病负担。
World J Gastroenterol. 2017 Dec 21;23(47):8263-8276. doi: 10.3748/wjg.v23.i47.8263.
3
Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.全球非酒精性脂肪性肝病流行病学——患病率、发病率和结局的荟萃分析评估。
Hepatology. 2016 Jul;64(1):73-84. doi: 10.1002/hep.28431. Epub 2016 Feb 22.
4
Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation.非酒精性脂肪性肝病和非酒精性脂肪性肝炎的流行病学:对肝移植的影响。
Transplantation. 2019 Jan;103(1):22-27. doi: 10.1097/TP.0000000000002484.
5
The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe.美国和欧洲非酒精性脂肪性肝病的经济和临床负担。
Hepatology. 2016 Nov;64(5):1577-1586. doi: 10.1002/hep.28785. Epub 2016 Sep 26.
6
Epidemiology and Natural History of Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病的流行病学与自然史
Semin Liver Dis. 2015 Aug;35(3):221-35. doi: 10.1055/s-0035-1562943. Epub 2015 Sep 17.
7
Epidemiology of Non-alcoholic Fatty Liver Disease in North America.北美地区非酒精性脂肪性肝病的流行病学。
Curr Pharm Des. 2020;26(10):993-997. doi: 10.2174/1381612826666200303114934.
8
Nonalcoholic steatohepatitis (NASH) - current treatment recommendations and future developments.非酒精性脂肪性肝炎(NASH)——当前的治疗建议及未来发展
Z Gastroenterol. 2019 Apr;57(4):508-517. doi: 10.1055/a-0784-8827. Epub 2019 Apr 9.
9
De Novo and Recurrence of Nonalcoholic Steatohepatitis After Liver Transplantation.肝移植后非酒精性脂肪性肝炎的新发与复发
Clin Liver Dis. 2017 May;21(2):321-335. doi: 10.1016/j.cld.2016.12.006. Epub 2017 Feb 1.
10
Nonalcoholic fatty liver disease in Asia: emerging perspectives.亚洲的非酒精性脂肪性肝病:新视角。
J Gastroenterol. 2017 Feb;52(2):164-174. doi: 10.1007/s00535-016-1264-3. Epub 2016 Sep 16.

引用本文的文献

1
Causal association between macrophage migration inhibitory factor and nonalcoholic fatty liver disease: A two-sample Mendelian randomization study.巨噬细胞移动抑制因子与非酒精性脂肪性肝病之间的因果关联:一项两样本孟德尔随机化研究。
Medicine (Baltimore). 2025 Sep 5;104(36):e44106. doi: 10.1097/MD.0000000000044106.
2
Biomarker discovery in NAFLD: insights from metabolomics and vote counting meta-analysis.非酒精性脂肪性肝病中的生物标志物发现:代谢组学与投票计数荟萃分析的见解
Metabolomics. 2025 Aug 12;21(5):116. doi: 10.1007/s11306-025-02312-5.
3
Is UA/HDL-C a Reliable Surrogate Marker for Fatty Liver? A Comparative Evaluation with Metabolic Scores in a Mexican Population: The Genetics of Atherosclerotic Disease Study.
尿酸/高密度脂蛋白胆固醇(UA/HDL-C)是脂肪肝的可靠替代标志物吗?墨西哥人群中与代谢评分的比较评估:动脉粥样硬化疾病遗传学研究
Diagnostics (Basel). 2025 Jun 3;15(11):1419. doi: 10.3390/diagnostics15111419.
4
Association between smoking status and non-alcoholic fatty liver disease.吸烟状况与非酒精性脂肪性肝病之间的关联。
PLoS One. 2025 Jun 9;20(6):e0325305. doi: 10.1371/journal.pone.0325305. eCollection 2025.
5
Optical coherence tomography angiography in non-alcoholic fatty liver disease: is it a disease affecting the microvascular system??非酒精性脂肪性肝病中的光学相干断层扫描血管造影:它是一种影响微血管系统的疾病吗??
BMC Ophthalmol. 2025 May 23;25(1):311. doi: 10.1186/s12886-025-04136-2.
6
Bridging the gap in obesity research: A consensus statement from the European Society for Clinical Investigation.弥合肥胖研究差距:欧洲临床研究学会的共识声明
Eur J Clin Invest. 2025 Aug;55(8):e70059. doi: 10.1111/eci.70059. Epub 2025 May 15.
7
INCIDENTAL HEPATIC STEATOSIS IDENTIFIED ON ULTRASOUND IN PATIENTS UNDERGOING CHOLECYSTECTOMY: HIGH PREVALENCE AND INSUFFICIENT INVESTIGATIVE AND CLINICAL MANAGEMENT.胆囊切除术患者超声检查发现的偶然肝脂肪变性:高患病率及调查和临床管理不足
Arq Gastroenterol. 2025 May 2;62:e24118. doi: 10.1590/S0004-2803.24612024-118. eCollection 2025.
8
The safety and efficacy of acupuncture in treating nonalcoholic fatty liver disease: A systematic review and meta-analysis based on randomized controlled trials.针刺治疗非酒精性脂肪性肝病的安全性和有效性:基于随机对照试验的系统评价和荟萃分析
Medicine (Baltimore). 2025 May 2;104(18):e42272. doi: 10.1097/MD.0000000000042272.
9
Ramadan Fasting and Complications of Metabolic Dysfunction-Associated Steatotic Liver Disease: Impacts on Liver Cirrhosis and Heart Failure.斋月禁食与代谢功能障碍相关脂肪性肝病的并发症:对肝硬化和心力衰竭的影响。
J Clin Med. 2025 Mar 9;14(6):1841. doi: 10.3390/jcm14061841.
10
Racial Disparities in Mortality Rates among Patients with Hepatic Steatosis, Non-Alcoholic Fatty Liver Disease, and Non-Alcoholic Steatohepatitis: Insights from NHANES III Data.肝脂肪变性、非酒精性脂肪性肝病和非酒精性脂肪性肝炎患者死亡率的种族差异:来自美国国家健康和营养检查调查(NHANES)III数据的见解
J Racial Ethn Health Disparities. 2025 Mar 4. doi: 10.1007/s40615-025-02317-9.